Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Group treatment for self-stigma in people with mental disorders in Northeast Italy

Official title: Assessing the Effectiveness and Feasibility of Group-based Treatment for Self-stigma in People With Mental Disorders: a Pragmatic Multisite Randomized Controlled Trial in Routine Mental Health Services in North-east Italy

Run by Universita di Verona · NCT06567145 · Data updated 2026-11-12

This study is testing a group therapy called Narrative Enhancement and Cognitive Therapy to see if it can help people with mental disorders in Northeast Italy feel better about themselves and reduce feelings of self-stigma.

More Mental Disorders trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment416 (estimated)
SponsorUniversita di Verona
Academic / other
Locations1 site (Verona)
StatusRecruiting
StartedOctober 1, 2024
Main results expectedOctober 1, 2025
Study endsOctober 1, 2025
Registry record updatedNovember 26, 2024
Trial IDNCT06567145 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older with specific mental health diagnoses who exhibit moderate levels of self-stigma.

Probably not a fit

Patients with primary personality disorders or substance dependence, as well as those unable to provide informed consent, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the efficacy and feasibility of Narrative Enhancement and Cognitive Therapy (NECT), a group-based intervention designed to reduce self-stigma among individuals with mental disorders. The trial involves 416 patients from 26 mental health centers in Northeast Italy and is structured as a pragmatic, multicenter, randomized controlled trial with two parallel arms. Participants will undergo 20 sessions of NECT, focusing on improving psychological dimensions such as self-esteem, hope, and empowerment while reducing self-stigma. The study aims to address the harmful effects of self-stigma on treatment adherence and quality of life.

Why it matters

Potential benefit: If successful, this intervention could significantly improve the self-esteem and quality of life for patients with mental disorders by reducing self-stigma.

How similar studies have gone: Previous studies have shown promising results in reducing self-stigma through similar therapeutic approaches, indicating potential for success in this trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Participants must be 18 years or older.
2. Individuals must have a diagnosis of schizophrenia, schizoaffective disorder, schizoid disorder, schizophreniform disorder, bipolar I or II disorder, or major depressive disorder, according to DSM-5 criteria.
3. Participants must be outpatients with clinical stability for at least 3 months, with no changes in pharmacological treatment during this period.
4. Participants must have sufficient knowledge of written and spoken Italian.
5. Participants must score above 1 on the ISMI (Internalized Stigma of Mental Illness) scale, indicating at least moderate levels of self-stigma.

Exclusion Criteria:

1. Individuals unable to provide informed consent are excluded.
2. Participants with intellectual disabilities are excluded.
3. Individuals with primary diagnosis of personality disorder or substance dependence condition are excluded.
4. Participants engaged in other programs that could influence self-stigma (e.g., social cognitive rehabilitation, social skills training) during the study are excluded.

Where it's running

  • Azienda Ospedaliera Universitaria Integrata (AOUI) Verona
    Verona, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.